Background Cytomegalovirus (CMV) remains the leading viral cause of disease following
orthotopic liver transplantation (OLT) despite the availability of antiviral agents for …

Context Cytomegalovirus (CMV) is an opportunistic infection that causes profound morbidity
and mortality after orthotopic liver transplant (OLT). The CMV immunoglobulin G …

This study compared the pre‐emptive and the prophylactic strategies used to prevent
cytomegalovirus (CMV) infection and disease in CMV‐seropositive orthotopic liver …

Background Few studies have directly compared preemptive therapy (PET) and antiviral
prophylaxis (AP) for prevention of cytomegalovirus (CMV) disease in CMV seropositive (R+) …

Background Cytomegalovirus (CMV) can cause severe infections in transplanted patients.
To prevent CMV infection, most liver centers use prophylaxis for CMV-seronegative …

Background The risk factors for development of viremia in high-risk donor cytomegalovirus
(CMV)-seropositive and recipient CMV-seronegative (D+ R−) transplant recipients are …

Clinical practice guidelines recommend antiviral prophylaxis to cytomegalovirus (CMV)
donor‐positive/recipient‐negative (D+/R−) liver transplant recipients. We assessed the …

BACKGROUND: Late-onset CMV disease is being increasingly recognized as a significant
post-transplantation complication. OBJECTIVES: To discern the impact of antiviral …

Background. The incidence and impact of cytomegalovirus (CMV) disease that occurs
despite CMV prophylaxis among liver transplant recipients have been incompletely defined …

BACKGROUND: With the introduction of prolonged prophylaxis with valganciclovir in
cytomegalovirus (CMV) donor/recipient serodiscordance (D+/R−) patients, concerns about a …